CLB Q1 2026 Earnings Call Summary

Core Laboratories (CLB) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Revenue: $121.8 million, down 12% sequentially and down 1% year-over-year.
Service Revenue: $94.3 million, down 12% sequentially and flat year-over-year.
Product Sales: $27.5 million, down 12% sequentially and down 3% year-over-year.
Operating Income (EBIT): $6.6 million (ex-items), down from $15.7 million in Q4 2025.
Net Income (ex-items): $2.7 million, down 72% sequentially and down 59% year-over-year; GAAP net loss of $800,000.
Earnings Per Share (EPS): $0.06 (ex-items), compared to $0.21 in Q4 2025 and $0.14 in Q1 2025; GAAP loss per share of $0.02.
Operating Margins: 5% for EBIT, down from 15% in Q4 2025.
Free Cash Flow: $500,000 after $3.5 million in CapEx.
Long-term Debt: $117 million; net debt increased to $94.2 million.

2. Strategic Updates and Business Highlights

Core Lab is focusing on technology innovation and operational efficiency despite geopolitical disruptions.
Continued commitment to shareholder returns through dividends and share repurchases, with over 51,000 shares repurchased in Q1.
Advancements in digital data strategy and proprietary technologies, including the rapid platform for reservoir data.
Strong demand for proprietary completion diagnostic services, particularly in the Gulf of Mexico.

3. Forward Guidance and Outlook

Q2 2026 revenue projected between $123 million and $131 million, with operating income of $6.4 million to $10.2 million.
Reservoir Description revenue expected to range from $77.5 million to $82.5 million; Production Enhancement revenue estimated at $45.5 million to $48.5 million.
EPS for Q2 2026 projected between $0.06 and $0.12.
Long-term outlook remains constructive, with anticipated growth in crude oil demand and the need for new oil and gas development.

4. Bad News, Challenges, or Points of Concern

Geopolitical conflicts, particularly in the Middle East and ongoing issues in Russia and Ukraine, have significantly disrupted operations and client activity.
Severe weather events in North America and Europe impacted operations and client completion activities.
Operating margins have declined sharply due to increased costs and reduced revenue, particularly in Reservoir Description and Production Enhancement segments.
Increased Days Sales Outstanding (DSOs) to 74 days, indicating slower collections due to geopolitical disruptions.

5. Notable Q&A Insights

CEO Larry Bruno confirmed no damage to Core Lab's infrastructure in the Middle East and expressed optimism for a rebound in operations once the conflict is resolved.
Discussion on the disconnect between physical and paper oil markets, with a growing urgency among national and international oil companies to develop resources closer to home for energy security.
Concerns about the complexity and potential duration of recovery in the Middle East were acknowledged, with emphasis on the need for infrastructure improvements post-conflict.
Increased demand for reservoir diagnostics and optimization services is expected as clients aim to recover lost production time.

This summary encapsulates the key points from Core Laboratories' Q1 2026 earnings call, highlighting financial performance, strategic initiatives, future outlook, challenges faced, and insights from the Q&A session.

CLB — Core Laboratories N.V.